Upgrade to SI Premium - Free Trial

Merck (MRK) PT Raised to $180 at Wolfe Research

August 25, 2026 5:35 AM
Wolfe Research analyst Alexandria Hammond raised the price target on Merck (NYSE: MRK) to $180.00 (from $155.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change